# A clinical study into the impact of brief aerobic exercise on the cardiopulmonary function of patients diagnosed with hyperlipidemia

**Authors:** Hua Zhang, Ya-Ru Ge, Li Feng, Jing Zhang, Ning Wang, Xiao-Yan Zhang, Cong Liu

PMC · DOI: 10.3389/fcvm.2025.1484693 · Frontiers in Cardiovascular Medicine · 2025-04-16

## TL;DR

This study found that short-term aerobic exercise improves cardiopulmonary function in hyperlipidemia patients but does not significantly affect lipid levels.

## Contribution

The study demonstrates the specific benefits of brief aerobic exercise on cardiopulmonary function in hyperlipidemia patients.

## Key findings

- The test group showed significantly higher MET values after 3 months of exercise.
- 6-minute walk distance and its percentage relative to predicted values improved significantly in the test group.
- Exercise did not significantly impact lipid levels or hyperlipidemia management.

## Abstract

The aim of this study was to examine the effectiveness of brief aerobic exercise on patients diagnosed with hyperlipidemia.

Seventy patients diagnosed with hyperlipidemia were enrolled from community health centers between May 2023 and October 2023. They were randomly assigned into two groups: test and control group, each consisting of 35 patients. The test group received personalized exercise recommendations along with routine medication, while the control group only received routine medication. The effectiveness of the intervention was assessed after 3 months. Various indicators including blood pressure, lipid levels, changes in cardiopulmonary function, 6-minute walk distance (6MWD) test results, the percentage of 6MWD relative to the predicted value (6MWD%Pred), copeptin (CPP), and fibroblast growth factor 21 (FGF21) were compared, before and after the intervention within each group and between the two groups.

After 3 months of personalized exercise, the test group showed significantly higher levels in three indicators compared to the control group. Specifically, the test group exhibited higher metabolic equivalent (MET) values [(x¯ ± SD, 4.6 ± 0.27 METs) vs. (x¯ ± SD, 3.8 ± 1.06 METs); P < 0.05], longer 6-minute walk distance (6MWD) [(x¯ ± SD, 488.08 ± 40.59 meters) vs. (x¯ ± SD, 366.76 ± 160.49 meters); P < 0.05], and a higher percentage of 6MWD relative to the predicted value (6MWD %Pred) [(x¯ ± SD, 92.8 ± 14.05) vs. (x¯ ± SD, 71.3 ± 30.69); P < 0.05]. Additionally, within the test group, there was a significant increase in MET, 6MWD, and 6MWD%Pred compared to baseline (P < 0.05).

Short-term aerobic exercise shows significant improvement in the cardiopulmonary function of patients with hyperlipidemia. However, it did not exhibit significant efficacy in managing hyperlipidemia.

## Linked entities

- **Proteins:** avp (arginine vasopressin)
- **Diseases:** hyperlipidemia (MONDO:0021187)

## Full-text entities

- **Genes:** AVP (arginine vasopressin) [NCBI Gene 551] {aka ADH, ARVP, AVP-NPII, AVRP, VP}, FGF21 (fibroblast growth factor 21) [NCBI Gene 26291]
- **Diseases:** hyperlipidemia (MESH:D006949)
- **Chemicals:** lipid (MESH:D008055)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12041006/full.md

## References

38 references — full list in the complete paper: https://tomesphere.com/paper/PMC12041006/full.md

---
Source: https://tomesphere.com/paper/PMC12041006